Infections are the most common and significant cause of mortality and morbidity after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). The presence of …

Umbilical cord blood (UCB) is an important source of hematopoietic stem cells (HSC) for
allogeneic transplantation when HLA-matched sibling and unrelated donors (MUD) are …

Purpose Improvement of cure rates for patients treated with allogeneic hematopoietic stem-
cell transplantation (HSCT) will require efforts to decrease treatment-related mortality from …

Haploidentical hematopoietic stem cell transplant (HSCT) provides an opportunity for nearly
all patients to benefit from HSCT. We conducted a trial of haploidentical T cell replete …

We enrolled 30 patients on a prospective phase II trial utilizing a total body irradiation (TBI)–
based myeloablative preparative regimen (fludarabine 30 mg/m 2/day× 3 days and TBI 150 …

BK virus (BKV) reactivation has been increasingly associated with the occurrence of late-
onset hemorrhagic cystitis (HC) after allogeneic hematopoietic SCT (allo-HSCT) resulting in …

Preventing viral infections at an early stage is a key strategy for successfully improving
transplant outcomes. Preemptive therapy and prophylaxis with antiviral agents have been …

Although hemorrhagic cystitis (HC) is a common complication of allogeneic hematopoietic
cell transplantation (alloHCT), its risk factors and effects on survival are not well known. We …

Background Hemorrhagic cystitis (HC) is a common complication after hematopoietic
allogeneic stem cell transplantation (HSCT) associated with intensity of the conditioning …

After allogeneic hematopoietic stem cell transplantation (HSCT), BK virus–associated
hemorrhagic cystitis (BKV-HC) is a common complication. Although supportive measures …